Latest Development Activity News

Golden Deeps Ltd has secured an 80% stake in Namibia’s Central Otavi Critical Metals Project and reported significant high-grade gallium intersections at its Nosib discovery, underpinning its expanding critical metals portfolio.

Provaris Energy has marked significant milestones in Q2 2025 with a key MOU with global shipping leader 'K' LINE and a joint venture formation with Yinson to commercialise proprietary hydrogen and carbon dioxide transport technologies.

QEM Limited has appointed Robert Cooper as its new CEO and secured $2.05 million in funding, while progressing key regulatory and technical milestones for its Julia Creek Vanadium and Energy Project.

Key Petroleum Limited has successfully placed all remaining shortfall shares from its recent entitlement offer, securing over A$312,000 in gross proceeds. This final step closes the capital raising round initiated in May 2025.

Hastings Technology Metals has formalized a 60 – 40 unincorporated joint venture with Wyloo for the Yangibana Rare Earths and Niobium Project, significantly reducing capital costs and advancing development. The company also moves to diversify with a conditional acquisition of the Whiteheads Gold Project and appoints Vince Catania as CEO.

Mithril Silver and Gold Limited reports strong exploration progress in Mexico’s Copalquin District with high-grade gold and silver assay results and a successful C$11.5 million private placement.

Tasman Resources progresses exploration at Lake Torrens and Parkinson Dam projects while managing capital through a recent entitlement offer and loan repayments.

Cadoux Limited has made significant progress in developing its high purity alumina and rare earths projects, advancing engineering design, customer engagement, and funding strategies during the June 2025 quarter.

Delorean Corporation has marked significant progress in Q4 FY2025, advancing its renewable gas infrastructure and securing crucial regulatory support that could unlock new revenue streams.

Audio Pixels Holdings reports a delay in its MEMS wafer production due to a key fabrication step requiring revision, while its shares remain suspended on the ASX. The company signals the need for additional funding within six months to sustain its R&D efforts.

Cambium Bio has cleared key regulatory hurdles for its lead dry eye disease treatment, Elate Ocular, and strengthened its balance sheet with a $2.12 million placement to support upcoming Phase 3 trials.

Northern Minerals reports strong progress on its Browns Range Heavy Rare Earths Project with key regulatory approvals, promising exploration results, and near-completion of its Definitive Feasibility Study amid tightening global supply.